The 'Week in Review' Podcast - 14 June

This is a preview of subscriber content

Subscribe now to continue reading.

It's a 'swear jar' episode during which we discuss the obsession with health technology assessment, why it is used to mask what is just price negotiation, meaning it takes too long, how decision-makers subordinate patient needs to this negotiation, and what the future could look like. Could it get even worse? …

Subscribe now to continue reading.

The 'Week in Review' Podcast - 14 June

This is a preview of subscriber content

Latest Video

Most Read

Historical change on pharmacy prescribing could be a sign of more to come

Victorian official appointed to HTA Review implementation advisory group

'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'

Proponents of meaningful reform might consider pharmacy prescribing as a case study

Sandoz summit promotes reform to boost the use of biosimilars

New Stories

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Rare Cancers Australia says election is the chance to end the ‘cancer lottery’

Specialised Therapeutics announces Thai approval of breast cancer therapy

Merck adds experienced industry executive to leadership team

Sandoz summit promotes reform to boost the use of biosimilars

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Sign In

The 'Week in Review' Podcast - 14 June

This is a preview of subscriber content

Latest Video

Most Read

Historical change on pharmacy prescribing could be a sign of more to come

Victorian official appointed to HTA Review implementation advisory group

'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'

Proponents of meaningful reform might consider pharmacy prescribing as a case study

Sandoz summit promotes reform to boost the use of biosimilars

Follow Us

New Stories

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Rare Cancers Australia says election is the chance to end the ‘cancer lottery’

Specialised Therapeutics announces Thai approval of breast cancer therapy

Merck adds experienced industry executive to leadership team

Sandoz summit promotes reform to boost the use of biosimilars

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus